The updated COVID-19 boosters from Pfizer Inc./BioNTech SE and Moderna helped prevent symptomatic infections against the new XBB-related subvariants, offering new evidence of how the vaccines perform against these fast-spreading strains, U.S. officials said today.
Tag Archive for: Covid-19
The multinational healthcare giant recorded overall medical device sales of $3.75 billion, missing analysts’ average estimate of $3.84 billion.
The U.S. health regulator proposed the use of one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it aims to simplify the country’s current COVID-vaccine strategy.
The subvariant is estimated to have accounted for 49.1% of COVID cases in the country in the week ended Jan. 21, compared with 37.2% estimated last week.
Sinopharm, now the China distributor of Merck & Co’s COVID-19 antiviral treatment molnupiravir, said its biotech unit received clinical trial approval from the National Medical Products Administration.
As our nation attempts to pick itself up and walk away from the COVID battlefield, we can see the toll it has suffered. COVID spurred a pervasive physical and mental health crisis in the United States, but it has also precipitated a financial and operational crisis among our most important healthcare institutions.
Last week the FDA and CDC flagged a potential link between the Pfizer/BioNTech coronavirus vaccine and stroke in older adults; today Israel’s coronavirus task force said it reviewed all its data and did not find an issue.
“EMA can confirm that to date no such signal has been identified in the EU. EMA will continue to evaluate all available data to determine whether emerging safety information could point to a similar signal in the EU,” the agency stated.
Moderna chief executive Stephane Bancel said on Wednesday the U.S. company was in active discussions to supply COVID-19 vaccines to China but gave no further details.
In an expansion of the company’s “An Accord for a Healthier World” program, which is aimed at increasing access to innovative treatments in some of the world’s poorest countries, Pfizer said it will now offer a total of 500 products.
